Microvascular Inflammation - MVI in Kindey Transplant Recipients

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Microvascular Inflammation - MVI in Kindey Transplant Recipients trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 4

NCT07274462

DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)

The DARA-MVI Study is a prospective, randomized, controlled, open-label trial designed to evaluate the effect of daratumumab on microvascular inflammation (MVI)…

Slovakia20 participantsStarted 2025-11-01

Treatment: DARATUMUMAB (DARZALEX®), Observation (Standard Care)